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Introduction
The transfusion of packed red blood cells (pRBCs) remains
a cornerstone in the management of many critically ill
children admitted in the paediatric intensive care units
(PICUs).1 An approximate 15 and 85 million pRBC units are
transfused annually in the United States and worldwide,
respectively.2,3 One explanation for the vast use of pRBC
transfusion may be the prevalence of anaemia in patients
admitted to the PICU. Anaemia has been found to be
present in 36.7% to 74% children admitted in PICUs; 15%
of them requiring pRBC transfusion.2,3 Furthermore, the
causes of anaemia are multi-factorial and include overt or
occult bleeding, iatrogenic bleeding, blood loss due to
underlying disease or illness severity, and treatment
causing bone marrow suppression.2 These anaemic
patients have been found to have higher paediatric risk of
mortality (PRISM) score, longer length of hospital stay (LOS)
and longer duration of mechanical ventilation compared
to patients without anaemia.2
The decision to transfuse pRBCs is based on the patient’s
haemoglobin (Hb) levels, clinical status, age categories in
terms of children, adolescents and infants as well as the
clinician’s expert opinion, common practice, and evidence
extrapolated from literature.4 Recent guidelines have
suggested a threshold of 5gm/dl of Hb for pRBC
transfusion, but the level of evidence is very low.5
However, the benefits of pRBC transfusions must be
cautiously weighed against its risks.6 There has been
increasing evidence showing association of pRBC
transfusion with increased mortality, longer PICU stay,
longer duration of mechanical ventilation, increased risks
of infections and transfusion reactions.1,7 There have also
been an increase in immune modulations, haemolysis,
transfusion-related acute lung injury (TRALI), alterations in
micro-circulations, allergic reactions and development of
multi-organ dysfunctions (MODs) in these patients.7,8 A
study in 2007 showed that red blood transfusion in
critically ill children is independently associated with
increased mortality, prolonged duration of mechanical
ventilation, infusions of vasoactive agents and PICU stay.9
Higher mortality rates were found among patients with
multiple transfusions.9 Patients who received pRBC
transfusion were 5 times more likely to die than patients
who did not receive pRBC transfusions, and similar
conclusions have been made by other studies.10
Hence, although pRBC transfusion is considered a
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potentially life-saving intervention with the aim of
improving adequate oxygen delivery to vital organs in
critically ill children, it is not a benign therapy.11 Further
prospective, randomised trials and retrospective studies as
well recent Transfusion and Anaemia Expertise Initiative
(TAXI) thereby suggest using a more conservative pRBC
transfusion in most scenarios.12 There has also been a lot
of emphasis on haemovigilance and pRBC sparing
strategies and goal-directed pRBC transfusion with the sole
purpose of increase tissue oxygen delivery.
The current study was planned to determine indications for
pRBC transfusion, and its association with outcomes in a
paediatric intensive care setting.
Materials and Methods
The retrospective study was conducted in the PICU of the
Aga Khan University Hospital (AKUH), Karachi, and
comprised data from January to December 2017, after
approval from the institutional ethics review committee.
AKUH is a 700-bed tertiary care university hospital with
laboratory and blood accredited with the College of
American Pathologists (CAP) and supervised by transfusion
medicine physicians. The practice of haemovigilance has
been implemented a few years ago, using a threshold of
Hb 7gm/dl for pRBC in critically ill stable, non-cyanotic
patients.13
Data retrieved from the hospital database comprised
records of all inpatients with age between 1 month and 16
years who received pRBC transfusions during the study
period. Data was excluded for patients weighing <3kg,
having postconceptionl age <40 weeks, and those
admitted with acute bleeding/haemorrhagic shock.
The data was collected using a structured proforma which
included patient demographics as well as clinical variables,
like the reason for PICU admission, paediatric risk of
mortality (PRISM) III score, multi-organ dysfunctions
(MODs) on admission or during PICU stay, requirement for
inotropic support/ mechanical ventilation, any surgical
procedure(s), reason for packed cell volume (PCV)
transfusion, number of PCV transfusion, volume of
transfusion and storage age of RBC. Also noted were
laboratory variables, like admission Hb, pre- and post-
transfusion Hb, lactic acid, blood gas values, blood culture
and sensitivity reports. Indication for pRBC transfusion was
taken from physician notes. Central line-associated blood
stream infection was defined as per the Center for Disease
Control and prevention (CDC) guidelines.14
The primary outcome was indication of pRBC transfusion,
pre- and post-transfusion Hb levels, length of mechanical
ventilation and PICU stay, and mortality in this group.
Data was analysed using SPSS 22 and results were
presented as mean with standard deviation and
frequencies with percentages. P value was determined to
assess the significance in groups using two sample t test
for normally distributed data and Wilcoxon rank sum test
for non-normal data. Univariate and multivariate logistic
regression was performed to calculate odds ratio (OR) for
outcome mortality with LOS, length of mechanical
ventilation and with liberal, defined as pre-transfusion Hb
>7gm/dl, and conservative RBC transfusion, defined as pre-
transfusion Hb <7gm/dl) group. P<0.05 was considered
statistically significant. Variables that were found to be
significant at 0.25 level of significance were considered for
multivariate analysis using stepwise forward model
selection method. 
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Table-1: Demographic and clinical data (n=147).
Variables n/mean ((%)/
SD/Median with IQR)
Mean Age (months) 67.89± 65.80
Gender Female 71 (48.3%)
Male 76 (51.7%)
PRISM III Median(IQR) 10(9)
Diagnostic Category Sepsis / Infection 50 (34.0%)
Respiratory Illnesses 26 (17.7%)
Haematological/Oncological 22 (15.0%)
Diseases
Neurological Illnesses 13 ( 8.8%)
Cardiovascular 10 ( 6.8%)
Miscellaneous 26 (17.7)
Indication of transfusion Low Haemoglobin 90 (61.2%)
Shock 29 (19.7%)
Hypoxia 28 (19.0%)
Storage age of Red Blood Cells 1-15 days 114 (77.6%)
16-30 days 26 (17.7%)
31-45 days 7 ( 4.8%)







Pre-transfusion haemoglobin <7 mg/dl 38 (25.9%)







Outcome (survived) Yes 88 (59.9%)
No 59 (40.1%)
Length of stay(days) Median(IQR) 6 (8)
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Results
During the study period, 600
patients were admitted in PICU,
with 210(35%) receiving pRBC
transfusion. Of them, 63(30%) did
not meet the inclusion criteria
and data related to them was
excluded. The final sample
comprised data of 147(70%)
patients. The overall mean age
was 67.89±65.8 months and
76(51.7%) of the patients were
males.  Mean PRISM score was
11.72±7.86. Admitting diagnosis




conditions, while indications for
transfusion included low Hb,
shock and hypoxia (Table 1).
Amongst the 147 transfusions,
114(77.6%) were aged <15 days,
26(17.7%) were aged 16-30 days,
and 7(4.8%) were aged 31-45






received three transfusions, while
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Table-2: Comparative data between patients who survived and those who expired (n=147).
Variables Expired Survived OR (CI) p-value adjusted OR(CI) p-value 
Age (months) 64.22±65.83 70.35±66.04 0.99(0.99,1.00) 0.579
Gender Male 51 (58.0%) 25 (42.4%) 1.87 (0.96,3.65) 0.065
Female 37 (42.0%) 34 (57.6%)
Indication Low Haemoglobin 55 (62.5%) 35 (59.3%) 0.87(0.44,1.71) 0.698
Shock. 16 (18.2%) 13 (22.0%) ------- -----
Hypoxia 17 (19.3%) 11 (18.6%) 0.79(0.27-2.28) 0.672
Storage Age of Red Blood Cells 1-15 Days 65 (73.9%) 49 (83.1%) 0.815(0.43,1.52) 0.524
16-30 Days 20 (22.7%) 6 (10.2%) 0.225(0.038-1.29)
31–45 Days 3 ( 3.4%) 4 ( 6.8%)
PRISM III Median(IQR) 13(12) 9(7) 1.10 (1.04,1.15) 0.000
Inotropic support yes 43 (49.4%) 51 (86.4%) 0.15(0.06,0.36) 0.000 0.22(0.08,0.60) 0.003
No 44 (50.6%) 8 (13.6%)
Mechanical Ventilation yes 65 (74.7%) 55 (93.2%) 0.21(0.06, 0.66) 0.007
no 22 (25.3%) 4 ( 6.8%)
Length of mechanical Ventilation 7.50±7.24 5.14±5.77 1.05(1.00, 1.11) 0.039 1.28(0.99,1.66) 0.053
MODS at admission yes 6 ( 6.8%) 29 (49.2%) 0.07(0.02,0.20) 0.000 0.12(0.04,0.38) 0.000
no 82 (93.2%) 30 (50.8%)
LOS (Mean) 8.66±8.11 8.23±8.107 1.00 (0.96,1.04) 0.756
OR: Odds ratio; CI: Confidence interval; PRISM: Paediatric risk of mortality; MODS: Multi-organ dysfunctions; LOS: Length of hospital stay.
Table-3: Comparison between pre-transfusion haemoglobin lesser or greater than 7 mg/dl (n=147). 
Haemoglobin Haemoglobin p-value
<7 mg/dl > 7mg/dl
Age (Mean±SD) 87.81±64.39 60.94±65.145 0.0297
Gender Male 17 (44.7%) 59 (54.1%) 0.320
Female 21 (55.3%) 50 (45.9%)
Diagnosis Neurological Illness 5 (13.2%) 8 ( 7.3%) 0.073
Cardiovascular diseases 4 (10.5%) 6 ( 5.5%)
Respiratory diseases 1 ( 2.6%) 25 (22.9%)
Gastrointestinal diseases 3 ( 7.9%) 5 ( 4.6%)
Renal diseases 1 ( 2.6%) 0 ( 0.0%)
Sepsis and infection related MODS 11 (28.9%) 39 (35.8%)
Post-operative 5 (13.2%) 11 (10.1%)
Haematological and oncological disease 8 (21.1%) 14 (12.8%)
Indication of transfusion Low Haemoglobin 22 (57.9%) 68 (62.4%) 0.200
Hypoxia 5 (13.2%) 23 (21.1%)
Shock 11 (28.9%) 18 (16.5%)
Transfusion Reaction Yes 0 ( 0.0%) 1 ( 0.9%) 0.550
No 38 (100.0%) 108 (99.1%)
Age of RBCS 1-15 days 29 (76.3%) 85 (78.0%) 0.970
16-30 days 7 (18.4%) 19 (17.4%)
31-45 days 2 ( 5.3%) 5 ( 4.6%)
MODS Yes 12 (31.6%) 23 (21.1%) 0.190
No 26 (68.4%) 86 (78.9%)
PRISM; Median(IQR) 10(7) 9(9) 0.973
Survived Yes 27 (71.1%) 61 (56.0%) 0.100
No 11 (28.9%) 48 (44.0%)
Inotropic support Yes 20 (52.6%) 74 (68.5%) 0.079
No 18 (47.4%) 34 (31.5%)
Surgery Yes 18 (47.4%) 47 (43.1%) 0.650
No 20 (52.6%) 62 (56.9%)
Mechanical ventilation Yes 27 (71.1%) 93 (86.1%) 0.037
No 11 (28.9%) 15 (13.9%)
Hospital Length of stay (Mean) 6.55±6.85 9.05±8.40 0.1006
SD: Standard deviation; RBCS: Red blood cells; PRISM: Paediatric risk of mortality; MODS: Multi-organ dysfunctions; LOS: Length of hospital stay.
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1(0.7%) patient each received four and five transfusions. Of
the total, 88(59.9%) patients survived; 48(57.1%) from
among those receiving one transfusion; 27(73%) among
those who received two transfusions and 13(54.2%)
survived from among those who received three
transfusions. There were no survivors from among those
who underwent four and five transfusions. Mean mixed
venous oxygen saturation, done in 82(55.8%) patients
before pRBC transfusion, was 58.1±14.7% and post-
transfusion, done in 25(17%) patients. was 61.2±16.2%.
Overall, 94(64%) patients required inotropic support and
120(82%) required mechanical ventilation with mean
length of mechanical ventilation was 6.11±6.5 days.
The mean length of stay in the PICU was 8.4±8.087days.
Mean values for PRISM score, length of mechanical
ventilation and PICU stay among the survivors were
significantly different compared to those who expired
(Table 2).
Comparison was also done on the basis of pre-transfusion
Hb level below or over the 7mg/dl cut-off (Table 3)
Discussion
Mean Hb threshold for pRBC transfusion in patients during
the current one-year audit was 7.87gm/dl, which is
according to global recommendations and the AKUH
protocol.13 However, recent transfusion guidelines
recommend even lower threshold of 5gm/dl Hb in stable
PICU patients.5 As such, there is room for improvement in
this aspect. Previous studies also suggested that
transfusing pRBCs at lower Hb threshold is better or at least
not worse than transfusing pRBCs at higher 
thresholds.15-17 Anaemia was the most common indication
for blood transfusion in the current study, which is in
accordance with literature.4 The incidence of anaemia
observed in the current study, however, was significantly
higher (55.9%) than the other studies.2,18,19 However, it is
of note that these studies were done in developed
countries and there is no known comparative data from
developing countries. Anaemia in PICU patients is multi-
factorial, resulting from underlying illness, pre-existing iron
deficiency, frequent laboratory testing etc.2 The post-
transfusion Hb level was around 10gm/dl which shows
adequate increase and practice of enough minimum
volume of transfusion to just bring Hb levels by 2gm/dl
above the pre-transfusion levels.13 Another important
thing to note is that in a small number of patients (25/147;
17%) post-transfusion mixed venous saturation mean
values only improved from 58% to 61%. This means that
probably the patients were either in shock or tissue oxygen
delivery did not improve much with pRBC transfusion. This
is very important point to consider while prescribing pRBC
transfusion in PICU as the aim of pRBC transfusion is to
improve arterial oxygen content and tissue oxygen
delivery.
RBC storage is another important point to consider while
transfusing pRBCs as this has also been associated with
worse outcomes.20 A study showed that pRBC storage of
>14 days was associated with prolonged LOS and
development of MODs.20 In a recent randomised controlled
trial (RCT), there was no difference in outcomes between
patients transfused fresh versus standard stored pRBCs.21
In our study more than two-thirds of patients received
pRBC storage life of 15 days or less and we did not find any
association of storage life of RBCs with adverse outcomes.
Overall, patients had a mortality of 40% which is a
considerably high incidence compared to earlier
studies.9,15,17,19 The patients who did not survive had a
higher overall PRISM score compared to the survivors.
These findings can also be extrapolated from another study
in a similar setting which concluded that critically ill
children with high PRISM score are also at a higher risk of
developing TRALI.22
One study showed mortality was independently associated
with the number of transfusions.9 In 2004, a study
concluded that the number of RBC units transfused to
intensive care patients with anaemia was an independent
predictor of a poor outcome.19 However, the current study
did not show such an association. Transfusion reaction was
also found to be rare (0.7%) among the patients and hence,
it could not be concluded if there was a direct relationship
between transfusion reactions and mortality.
Furthermore, patients in the current study had an increased
length of mechanical ventilation and increased hospital
stay. Similar finding was reported by another study in
which RBC transfusion was independently associated with
longer duration of mechanical ventilation in paediatric
patients with acute respiratory syndrome.17 Patients who
were transfused with a restrictive strategy had similar or
better outcomes and requirement of inotropes as those
with liberal transfusion strategies which has also been
shown by previous studies.15,16
The current study has certain limitations, including
retrospective nature with limited number at a single centre
without any control group. Another important aspect that
the study did not look at was wastage of blood products
and cost implications of excessive or unnecessary pRBC
transfusions. Quite often, more pRBC units are provided
than required, and the leftover is discarded which can be
easily prevented by ordering accurate volume of blood.
Despite the limitations, the current study has highlighted
1971
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some important practice trends in RBC transfusion in AKUH
PICU. We continue to work more collaboratively with our
haemovigilance team to decrease threshold of pRBC
transfusion and use it judiciously in number as well in
volume. We also strongly suggest that hospital systems and
physicians work with blood bank and make a
haemovigilance team to make the use of blood and blood
products safe, rationale and judicious. It will be a cost-
effective strategy since it will save cost as well as adverse
effects of blood products, and make it available for more
patients.
Conclusion
Transfusion of pRBC, which is frequently prescribed in PICU
settings, was not found to be associated with favourable
outcome. It is commonly prescribed with a threshold
higher than the recommended Hb levels. Haemovigilance
can be of great help in restricting unnecessary use of pRBC
in PICUs.
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